Astrazeneca leads FTSE 100 higher on strong sales momentum
Pharmaceutical giant AstraZeneca (AZN) reported third quarter revenues up 18% to $6.1bn in constant currencies, beating analyst expectations by 5%. The shares traded 3.5% higher at £71.68, topping the list of FTSE 100 gainers.Chief...
24 October 2019